Publicaciones (20) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. Effect of AT 1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: Role of NF-κB/IκB system

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 288, Núm. 1 57-1

  2. CHOP plays a pivotal role in the astrocyte death induced by oxygen and glucose deprivation

    GLIA, Vol. 52, Núm. 4, pp. 261-275

  3. Dpp signaling and the induction of neoplastic tumors by caspase-inhibited apoptotic cells in Drosophila

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 49, pp. 17664-17669

  4. Eplerenone reduces oxidative stress and enhances eNOS in SHR: Vascular functional and structural consequences

    Antioxidants and Redox Signaling, Vol. 7, Núm. 9-10, pp. 1294-1301

  5. Evaluación del paciente con crisis convulsivas

    JANO, Vol. 69, pp. 236-240

  6. Factores determinantes de la prescripción farmacológica en los pacientes con EPOC estable. Resultados de un estudio multicéntrio español (IDENTEPOC)

    Archivos de Bronconeumologia, Vol. 41, Núm. 2, pp. 63-70

  7. Farmacológicas controversies reflected in the guides and national and international norms

    Archivos de Bronconeumologia, Vol. 41, Núm. SUPPL. 2, pp. 32-37

  8. Fármacos antihipertensivos y aterogénesis

    Clínica e investigación en arteriosclerosis, Vol. 17, Núm. 1, pp. 16-24

  9. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 2, pp. 287-291

  10. Herpes Simplex Virus Type 1 Infection via the Bloodstream with Apolipoprotein E Dependence in the Gonads Is Influenced by Gender

    Journal of Virology, Vol. 79, Núm. 3, pp. 1605-1612

  11. Insulin-like growth factor I treatment for cerebellar ataxia: Addressing a common pathway in the pathological cascade?

    Brain Research Reviews, Vol. 50, Núm. 1, pp. 134-141

  12. Las estatinas como antioxidantes

    Clínica e investigación en arteriosclerosis, Vol. 17, Núm. 2, pp. 23-30

  13. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804

  14. Low-fat dairy consumption and reduced risk of hypertension: The Seguimiento Universidad de Navarra (SUN) cohort

    American Journal of Clinical Nutrition, Vol. 82, Núm. 5, pp. 972-979

  15. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: Role of the NFκB/IκB system

    Journal of Hypertension, Vol. 23, Núm. 6, pp. 1167-1172

  16. Skeletal muscle

    Advances in Experimental Medicine and Biology, Vol. 567, pp. 117-147

  17. Study of the main motivations and discouraging factors for the implementation of ISO 9000 standards in Spanish agribusiness sector

    Journal of International Food and Agribusiness Marketing, Vol. 17, Núm. 2, pp. 229-243

  18. Una férula digital

    FMC: Formación Médica Continuada en Atención Primaria, Vol. 12, Núm. 10, pp. 676-678

  19. Validación del cuestionario de satisfacción con el tratamiento antirretroviral: Cuestionario CESTA

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 10, pp. 586-592

  20. Validation of self reported diagnosis of hypertension in a cohort of university graduates in Spain

    BMC Public Health, Vol. 5